|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
BROLUCIZUMAB |
S01LA06 |
FR
|
I
|
22-04-2020 |
EMEA/H/C/004913 |
13-02-2020 |
VALID
|
|
BROMOCRIPTINE |
G02CB01 |
FR
|
I
|
|
None |
28-09-2001 |
VALID
|
|
BUDESONIDE |
A07EA06 |
FR
|
I
|
|
|
|
VALID
|
|
BUDESONIDE |
R01AD05 |
FR
|
I
|
17-05-2018 |
|
|
VALID
|
|
BULEVIRTIDE |
J05AX28 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/004854 |
31-07-2020 |
VALID
|
|
BUPIVACAINE AND MELOXICAM |
N01BB59 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005205 |
24-09-2020 |
VALID
|
|
BUPRENORPHINE |
N02AE01 |
FR
|
I
|
|
FR/H/0147/003/ |
16-01-2015 |
VALID
|
|
BUPRENORPHINE |
N07BC01 |
FR
|
I
|
|
None |
|
VALID
|
|
BUPRENORPHINE, COMBINATIONS |
N07BC51 |
FR
|
I
|
19-07-2023 |
EMEA/H/C/004407 |
10-11-2017 |
VALID
|
|
BUROSUMAB |
M05BX05 |
FR
|
I
|
10-04-2018 |
EMEA/H/C/004275 |
19-02-2018 |
VALID
|
|
BUTYLSCOPOLAMINE |
A03BB01 |
FR
|
I
|
|
|
|
VALID
|
|
CABAZITAXEL |
L01CD04 |
FR
|
I
|
18-08-2017 |
EMEA/H/C/002018 |
17-03-2011 |
VALID
|
|
CABERGOLINE |
G02CB03 |
FR
|
I
|
05-02-2019 |
|
28-09-2001 |
VALID
|
|
CABOTEGRAVIR |
J05AJ04 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/004976 |
17-12-2020 |
VALID
|
|
CABOZANTINIB |
L01EX07 |
FR
|
I
|
07-11-2016 |
EMEA/H/C/002640 |
21-03-2014 |
VALID
|
|
CALCIUM FOLINATE |
V03AF03 |
FR
|
I
|
|
|
|
VALID
|
|
CALCIUM LEVOFOLINATE |
V03AF04 |
FR
|
I
|
|
|
|
VALID
|
|
CANAGLIFLOZIN |
A10BK02 |
FR
|
I
|
18-08-2017 |
EMEA/H/C/002649 |
15-11-2013 |
VALID
|
|
CANDESARTAN |
C09CA06 |
FR
|
I
|
|
|
|
VALID
|
|
CANNABIDIOL |
N03AX24 |
FR
|
I
|
05-03-2021 |
|
|
VALID
|
|
CANNABINOIDS |
N02BG10 |
FR
|
I
|
|
|
|
VALID
|
|
CAPECITABINE |
L01BC06 |
FR
|
I
|
|
|
|
VALID
|
|
CAPIVASERTIB |
L01EX27 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/006017 |
17-06-2024 |
VALID
|
|
CAPLACIZUMAB |
B01AX07 |
FR
|
I
|
12-11-2018 |
EMEA/H/C/004426 |
27-08-2018 |
VALID
|
|
CAPMATINIB |
L01EX17 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/004845 |
20-06-2022 |
VALID
|
|
CARBIMAZOLE |
H03BB01 |
FR
|
I
|
|
|
|
VALID
|
|
CARBOHYDRATES |
B05BA03 |
FR
|
I
|
|
FR/H/0217/001/ |
19-04-2015 |
VALID
|
|
CARGLUMIC ACID |
A16AA05 |
FR
|
I
|
|
|
|
VALID
|
|
CARMUSTINE |
L01AD01 |
FR
|
I
|
|
FR/H/0141/001/II/009 |
27-07-2005 |
VALID
|
|
CARTEOLOL |
S01ED05 |
FR
|
I
|
|
FR/H/0388/002/ |
20-12-2013 |
VALID
|
|
CARVEDILOL |
C07AG02 |
FR
|
I
|
|
|
|
VALID
|
|
CASIRIVIMAB AND IMDEVIMAB |
J06BD07 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005814 |
12-11-2021 |
VALID
|
|
CATUMAXOMAB |
L01FX03 |
FR
|
I
|
02-05-2025 |
EMEA/H/C/005697 |
10-02-2025 |
VALID
|
|
CEFEPIME AND BETA-LACTAMASE INHIBITOR |
J01DE51 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005431 |
21-03-2024 |
VALID
|
|
CEFIDEROCOL |
J01DI04 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/004829 |
23-04-2020 |
VALID
|
|
CEFIXIME |
J01DD08 |
FR
|
I
|
21-10-2019 |
PT/H/1696/001/DC |
06-06-2018 |
VALID
|
|
CEFTAROLINE FOSAMIL |
J01DI02 |
FR
|
I
|
|
|
|
VALID
|
|
CEFTAZIDIME AND BETA-LACTAMASE INHIBITOR |
J01DD52 |
FR
|
I
|
|
EMEA/H/C/004027 |
24-06-2016 |
VALID
|
|
CEFTOLOZANE AND BETA-LACTAMASE INHIBITOR |
J01DI54 |
FR
|
I
|
|
EMEA/H/C/003772 |
18-09-2015 |
VALID
|
|
CEFTRIAXONE |
J01DD04 |
FR
|
I
|
|
None |
|
VALID
|
|
CEFUROXIME |
S01AA27 |
FR
|
I
|
|
None |
26-09-2012 |
VALID
|
|
CELECOXIB |
M01AH01 |
FR
|
I
|
|
|
|
VALID
|
|
CEMIPLIMAB |
L01FF06 |
FR
|
I
|
|
EMEA/H/C/004844 |
27-06-2019 |
VALID
|
|
CENEGERMIN |
S01XA24 |
FR
|
I
|
29-01-2018 |
EMEA/H/C/004209 |
06-07-2017 |
VALID
|
|
CENOBAMATE |
N03AX25 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005377 |
26-03-2021 |
VALID
|
|
CERITINIB |
L01ED02 |
FR
|
I
|
07-04-2016 |
EMEA/H/C/003819 |
06-05-2015 |
VALID
|
|
CERLIPONASE ALFA |
A16AB17 |
FR
|
I
|
29-01-2018 |
EMEA/H/C/004065 |
30-05-2017 |
VALID
|
|
CERTOLIZUMAB PEGOL |
L04AB05 |
FR
|
I
|
|
|
|
VALID
|
|
CERTOPARIN |
B01AB13 |
FR
|
I
|
27-02-2023 |
None |
|
VALID
|
|
CETUXIMAB |
L01XC06 |
FR
|
I
|
|
|
|
VALID
|
